The role of the abundant phenylalanines in the mode of action of the antimicrobial peptide clavanin

Biochimica et Biophysica Acta - Biomembranes

Volumn 1615, Issue 1-2, 2003, Pages 84-92

  Van Kan, Ellen J M ^a   Demel, Rudy A ^b   Van Der Bent, Arie ^a   De Kruijff, Ben ^b  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Antibiotic; Biomembrane; Mechanism; Model membrane; Peptide; Phenylalanine

Indexed keywords

AMINO ACID; ANTIINFECTIVE AGENT; CLAVANIN A; ISOLEUCINE; LEUCINE; MEMBRANE LIPID; PHENYLALANINE; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG;

ACIDITY; ALPHA HELIX; AMINO ACID ANALYSIS; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG CONFORMATION; DRUG MECHANISM; DRUG STRUCTURE; EXPERIMENTAL MODEL; HYDROPHILICITY; MACROMOLECULE; MEMBRANE PERMEABILITY; MUTANT; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTON TRANSPORT; STRUCTURE ANALYSIS; WILD TYPE;

EID: 0042510131     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(03)00233-5     Document Type: Article

References (43)

1. Van Kan E.J.M., Demel R.A., Breukink E., Van der Bent A., De Kruijff B. Clavanin permeabilizes target membranes via two distinctly different pH dependent mechanisms. Biochemistry. 41:2002;7529-7539.
2. Boman H.G. Gene-encoded peptide antibiotics and the concept of innate immunity: an update review. Scandinavian Journal of Immunology. 48:1998;15-25.
3. Nissen-Meyer J., Nes I.F. Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action. Archives of Microbiology. 167:1997;67-77.
4. Lehrer R.I., Ganz T. Endogenous vertebrates antibiotics - defensins, protegrins, and other cysteine-rich antimicrobial peptides. Annals of the New York Academy of Sciences. 797:1996;228-239.
5. Gudmundsson G.H., Agerberth B. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. Journal of Immunological Methods. 232:1999;45-54.
6. Boman H.G. Antibacterial peptides: key components needed in immunity. Cell. 65:1991;205-207.
7. Epand R.M., Vogel H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochimica et Biophysica Acta. 1462:1999;11-28.
8. Blondelle S.E., Lohner K., Aguilar M.-I. Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: determination and biological specificity. Biochimica et Biophysica Acta. 1462:1999;89-108.
9. Dathe M., Wieprecht T. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochimica et Biophysica Acta. 1462:1999;71-87.
10. Dathe M., Schümann M., Wieprecht T., Winkler A., Beyermann M., Krause E., Matsuzaki K., Murase O., Bienert M. Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry. 35:1996;12612-12622.
11. Hong J., Oren Z., Shai Y. Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes. Biochemistry. 38:1999;16963-16973.
12. Van 't Hof W., Veerman E.C.I., Helmerhorst E., Van Nieuw Amerongen A. Antimicrobial peptides: properties and applicability. Biological Chemistry. 382:2001;597-619.
13. Tossi A., Sandri L., Giangaspero A. Amphipathic, α-helical antimicrobial peptides. Biopolymers. 55:2000;4-30.
14. Matsuzaki K., Nakamura A., Murase O., Sugishita K., Fujii N., Miyajima K. Modulation of magainin 2-lipid bilayer interactions by peptide charge. Biochemistry. 36:1997;2104-2111.
15. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochimica et Biophysica Acta. 1462:1999;1-10.
16. Huang H.W. Action of antimicrobial peptides: two state model. Biochemistry. 39:2000;8347-8352.
17. Nicolas P., Mor A. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annual Review of Microbiology. 49:1995;277-304.
18. Oren Z., Shai Y. Mode of action of linear amphipathic a-helical antimicrobial peptides. Biopolymers. 47:1999;451-463.
19. Wieprecht T., Dathe M., Epand R.M., Beyermann M., Krause E., Maloy W.L., MacDonald D.L., Bienert M. Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Biochemistry. 36:1997;12869-12880.
20. Sitaram N., Nagaraj R. Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity. Biochimica et Biophysica Acta. 1462:1999;29-54.
21. Lehrer R.I., Lee I.H., Menzel L., Waring A., Zhao C. Clavanins and styelins, a-helical antimicrobial peptides from the hemocytes of Styela clava. Advances in Experimental Medicine and Biology. 484:2001;71-76.
22. Lee I.H., Zhao C., Cho Y., Harwig S.S.L., Cooper E.L., Lehrer R.I. Clavanins, α-helical antimicrobial peptides from tunicate hemocytes. FEBS Letters. 1997;158-162.
23. Zhao C., Liaw L., Lee I.H., Lehrer R.I. cDNA cloning of clavanins: antimicrobial peptides of tunicate hemocytes. FEBS Letters. 410:1997;490-492.
24. Van Kan E.J.M., Van der Bent A., Demel R.A., De Kruijff B. Membrane activity of the peptide antibiotic clavanin and the importance of its glycine residues. Biochemistry. 40:2001;6398-6405.
25. Lee I.H., Cho Y., Lehrer R.I. Effects of pH and salinity on the antimicrobial properties of clavanins. Infection and Immunity. 65:1997;2898-2903.
26. Wimley W.C., White S.H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nature Structural Biology. 3:1996;842-848.
27. Weinstein J.N., Ralston E., Leserman L.D., Klausner R.D., Dragsten P., Henkart P., Blumenthal R. Self-quenching of carboxyfluorescein: fluorescence: uses in studying liposome stability and liposome-cell interaction. Gregoriadis G. Liposome Technology. 1984;183-204 CRC Press, Boca Raton, FL.
28. Sims P.J., Waggoner A.S., Wang C.H., Hoffmann J.R. Mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles. Biochemistry. 13:1974;3315-3330.
29. Demel R.A. Monomolecular layers in the study of biomembranes. Hilderson H.J., Ralston G.B. Subcellular Biochemistry. 1994;83-120 Plenum press, New York.
30. Hope M.J., Bally M.B., Webb G., Cullis P.R. Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochimica et Biophysica Acta. 812:1985;55-62.
31. Rouser G., Fleischer S., Yamamoto A. Two-dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids. 5:1970;494-496.
32. Chen Y.H., Yang J.T., Martinez H.M. Determination of the secondary structure from circular dichroism. Biochemistry. 11:1972;4120-4131.
33. Curtis Johnson W. Protein secondary structure and circular dichroism: a practical guide. Proteins: Structure, Function, and Genetics. 7:1990;205-214.
34. Pelton J.T., McLean L.R. Spectroscopic methods for analysis of protein secondary structure. Analytical Biochemistry. 277:2000;167-176.
35. Wieprecht T., Dathe M., Beyermann M., Krause E., Lee Maloy W., MacDonald D.L., Bienert M. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry. 36:1997;6124-6132.
36. Shai Y., Oren Z. Diastereomers of cytolysins, a novel class of potent antibacterial peptides. The Journal of Biological Chemistry. 271:1996;7305-7308.
37. Dathe M., Nikolenko H., Meyer J., Beyermann M., Bienert M. Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Letters. 501:2001;146-150.
38. Dathe M., Wieprecht T., Nikolenko H., Handel L., Maloy W.L., MacDonald D.L., Beyermann M., Bienert M. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Letters. 403:1997;208-212.
39. Besalle R., Gorea A., Shalit I., Metzger J.W., Dass C., Desiderio D.M., Fridkin M. Structure-function studies of amphiphilic antibacterial peptides. Journal of Medicinal Chemistry. 36:1993;1203-1209.
40. Avrahami D., Oren Z., Shai Y. Effect of multiple aliphatic amino acids substitutions on the structure, function, and mode of action of diastereomeric membrane active peptides. Biochemistry. 40:2001;12591-12603.
41. Brown R.E. Sphingolipid organization in biomembranes: what physical studies of model membranes reveal. Journal of Cell Science. 111:1998;1-9.
42. Speelmans G., Staffhorst R.W.H.M., De Kruijff B., De Wolf F.A. Transport studies of doxorubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflets of the plasma membrane. Biochemistry. 33:1994;13761-13768.
43. Eisenberg D., Weiss R.M., Terwilliger T.C. The hydrophobic moment detects periodicity in protein hydrophobicity. Proc. Nat. Acad. Sci. USA. 81:1984;140-144.